1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow olaratumab: new trials by email Literature Review of olaratumab trials Research Report on olaratumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Olaratumab, Doxorubicin, Placebo - Soft Tissue Sarcoma | Phase 3 | Completed | Eli Lilly and Company | 509 | 2015-09-14 | 2025-07-15 |
Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Liposarcoma (1) · Sarcoma (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1) · Mexico (1)
PMID 28447475, PMID 32259228, PMID 33632930
2015 (1)